The Duke Endowment of Charlotte, N.C., is supporting Duke University’s efforts to expand its faculty in computation, materials science and the resilience of the body and brain by completing the second phase of a $100 million investment.
A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections — including SARS-CoV-2 as well as the original SARS-CoV-1 and related bat coronaviruses that could potentially cause the next pandemic. The findings were published in the journal Nature.
Twin 9-year-old girls at Duke Health became the first in the United States to participate in a Pfizer and BioNTech Phase 1 study to evaluate safety, tolerability and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine in preventing COVID-19 among healthy children below the age of 12.
More than 5.3 million individuals — children and adults — permanently live with a brain injury-related disability, according to the Brain Injury Association of America. Two researchers from the Duke University School of Nursing, Tolu O. Oyesanya, PhD, RN, and Karin Reuter-Rice, PhD, CPNP-AC, FCCM, FAAN, have devoted an aspect of their research toward better understanding the ramifications that brain injuries inflict on patients and their loved ones and how to give them the best health care possible.
Answering a long-standing need in the community for enhanced behavioral health services, Duke Health is opening a newly built center at Duke Regional Hospital that will provide a setting specifically designed for the comfort and care of these patients.
What if we could disable the defense mechanisms that enable cancer cells to evade treatment, or even control their genes to prevent them from developing into tumors in the first place? Can we enhance our brain’s ability to forestall damage from Alzheimer’s disease and other neurodegenerative conditions? Is it possible to develop a vaccine for everything?
Yvonne Mowery, MD, PhD, Butler Harris Assistant Professor in Radiation Oncology, is one of many physician-scientists at Duke who credits the Duke University School of Medicine’s Strong Start Program for her career growth.
Michael Boyce, PhD, associate professor of biochemistry, never expected to be studying the lungs. He is an expert in glycobiology—the intricate mechanisms behind how sugars attach to proteins, and the role these sugars play in sending signals that influence cell biology, organ function, and more.
With sepsis, time is of the essence. Left untreated, the illness—a runaway immune response to infection—can quickly become life-threatening. Duke hospital medicine physician Cara O’Brien, MD, is partnering with the Duke Institute for Health Innovation to lead a multidisciplinary team of physicians, nurses, and biostatisticians that is using data science to rapidly identify at-risk patients, speed treatment, and improve outcomes.
Through the Regeneration Next Initiative, Duke researchers are gaining insights into how to stimulate heart muscle to regrow after injury.